Structural investigation of Lisinopril by powder X-ray diffraction and solid-state NMR

Structural studies on polycrystalline Lisinopril (N-N-[(s)-1-carboxy-3-phenylpropyl]-L-lysil-L-proline) are performed by combined powder X-Ray diffraction and 13C solid-state nuclear magnetic resonance (NMR). The crystal structure of this drug, used primarily for the treatment of hypertension, has not yet been determined due to the impossibility of synthesizing single crystals of sufficient quality. It is shown here that valuable insights into the crystal and molecular structure of Lisinopril can be obtained on polycrystalline powder based on the complementary character of the information provided by the two techniques.